by
Ilse ZolleIlse Zolle
Radioactive drug development is a multi-disciplinary task, therefore, in a concerted effort, dedicated scientists and experts from different fields of specialisation have contributed to this book. It is presented in two sections. Section 1 contains basic principles and methods used for analysis, information on the chemistry of technetium and on radiopharmaceuticals labelled with technetium-99m, the characteristics of the 99 Mo/99mTc-generator, of ‘kits’ and formulations for in-vitro labelling, and special safety aspects for in-vivo labelling of blood cells. Section 2 contains monographs of 99mTc-radiopharmaceuticals used in nuclear medicine. Each monograph includes information on the chemistry, formulation, commercial products and trade names, factors affection in-vivo performance, clinical information on pharmacokinetics, as well as details concerning the clinical application and the radiation dose to patients. Written for: Radiochemists, Radiopharmacists, Nuclear Medicine Physicians
Product Details
| ISBN-13: | 9783540339892 | |
| Publisher: | Springer Berlin Heidelberg | |
| Publication date: | 11/07/2006 | |
| Edition description: | 2007 | |
| Pages: | 345 | |
| Product dimensions: | 6.10(w) x 9.25(h) x 0.03(d) |
